DocWire News Editors

DocwireNews

During AAO 2019, two posters pertaining to the use of optical coherence tomography (OCT) were discussed.The first poster, &ldquo;Filigree Vascular Pattern in Combined Hamartoma of Retina and RPE on OCT-A,&rdquo; assessed the vascular structure comprising combination retina hamartoma and retinal pigment epithelium (CHRRPE) lesions using OCT angiography (OCT-A). The study included 20 eyes diagnosed with CHRRPE, which underwent color fundus photographs, OCT, and OCT-A. The primary outcome measure was the density of flow signals&rsquo; &ldquo;filigree&rdquo; vascular pattern via OCT-A analyzed at deep capillary plexus graded as high (&gt; 20), intermediate (10-20), or low (&lt; 10). The most common location was peripapillary (n = 11), followed by macular (n = 8); one was located at the equatorial. Of the peripapillary CHRRPE lesions with full-thickness retinal involvement, 10 presented a high density of filigree vascular pattern. Most of the macular lesions with partial-thickness retinal involvement and preretinal fibrosis (n = 7/8) exhibited a low density of filigree pattern.The second poster presented data from a retrospective study that examined the use of ultrawide-field OCT (UWF-OCT), which offers high-resolution images of posterior fundi, in posterior vitreous in myopic macular retinoschisis (MRS) patients. Data were available on 150 highly myopic eyes. Twelve radial scans of UWF-OCT identified posterior vitreous. Researchers compared the vitreal tractions onto the fovea and retinal vessels in eyes with and without MRS. Overall, 33% of eyes (n = 49/150) presented MRS. Compared to those without MRS, eyes with MRS were more likely to have complicated staphyloma (P = 0.04) and vitreal adhesion onto retinal vessels (P = 0.04). Adhesion onto the fovea did not largely differ between the two groups. The authors concluded that foveal adhesion may not be as significant for MRS development than pathological vitreal adhesion.

Jayme Locke, MD, MPH

Joel M. Topf, MD, FACP

The Promise of Xenotransplantation

NKF Spring Clinical Meetings 2025

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Sacituzimab Govitecan Showed Modest Activity for CNS Metastases

Triple-Negative Breast Cancer

Latest News

Optical Coherence Tomography in CHRRPE and MRS Eyes

Ophthalmology

During AAO 2019, two posters pertaining to the use of optical coherence tomography (OCT) were discussed. ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe